CD28 protein-coupled magnetic MicroBeads

• Cat.No.: CD28-503M

Specification

• Species: Human
• Capacity: for 1×10^9 total cells
• Background: The CD28+ cells are indirectly magnetically labeled with CD28-PE and Anti-PE MicroBeads.
  The CD28 antigen is a type I trans‑membrane protein, highly expressed on most CD4+ T cells, many CD8+ T cells, and on malignant plasma cells (myeloma cells). Ligation of CD28 with CD80 (B7-1) or CD86 (B7-2) on target cells provides a critical costimulatory signal for T cell activation. Blockade of CD28-B7 interaction leads to an inhibition of immune responses both in vivo and in vitro.
• Application: The CD28 MicroBead Kit was developed for the isolation of CD28+ cells from PBMCs, e.g., for phenotypical or functional characterization.
  CD28+ T cell subsets can be isolated in combination with kits for untouched T cell isolation, e.g., the CD4+ T Cell Isolation Kit or the CD8+ T Cell Isolation Kit.

Reviews

08/24/2021

Its unique characteristics contribute to obtaining clear and detailed structural information, enabling researchers to unravel the intricate complexities of protein interactions and conformational changes.

08/24/2021

Researchers can confidently rely on its capabilities to generate precise and significant results, enhancing the understanding of protein function and dynamics.

08/06/2021

the CD28 protein's outstanding performance in ELISA and its utility in protein electron microscopy structure analysis make it a highly recommended tool for researchers.

Q&As

Can CD28 protein be used for personalized medicine?

CD28 protein expression and function may be relevant for personalized treatment strategies in autoimmune diseases and cancer.

What are the potential clinical applications of targeting CD28 protein?

Targeting CD28 protein may have therapeutic potential in treating autoimmune diseases, cancer immunotherapy, and organ transplantation.

How does CD28 protein impact regulatory T cells (Tregs)?

CD28 signaling is important for the function and maintenance of regulatory T cells, which play a role in immune tolerance and suppression of autoimmunity.

How does CD28 protein impact cancer immunotherapy?

CD28 protein is involved in enhancing the anti-tumor immune response, making it a potential target for cancer immunotherapy.

Are there any approved therapies targeting CD28 protein?

Currently, there are no FDA-approved therapies specifically targeting CD28 protein, but research is ongoing in this area.